Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Long-term Transcatheter Aortic Valve Durability
Author(s): Giuliano Costa , Enrico Criscione , Denise Todaro , et al Added: 3 years ago
Aortic stenosis (AS) is one of the most common valvular diseases in developed countries and its prevalence is projected to increase over the next decade as the population ages.1,2 Transcatheter aortic valve implantation (TAVI) is an established alternative to surgery for treatment of patients with symptomatic, severe AS.3 As the latest multicentre trials have established the role of TAVI… View more

Vascular Disease and Surgery

Intervention
Author(s): Ren Jie Yao , Matheus Simonato , Danny Dvir Added: 3 years ago
In the context of an ageing population, care for valvular disease is becoming an increasingly important field. A recent large-scale population-based study found the prevalence of valvular disease to be 8.5 % in the 65–74-year-old group and 13.2 % in those over 75 years. 1 While mechanical surgical valves are more durable, bioprosthetic valves are often used as they are less thrombogenic and do… View more

Vascular Disease and Surgery

Intervention
Author(s): Christian Spies , Ziyad M Hijazi Added: 3 years ago
Unlike the left-sided semi-lunar valve, clinically significant acquired pulmonary valve disease is rare. However, stenotic or regurgitant pulmonary valve lesions are not uncommon following surgery for congenital heart defects, including tetralogy of Fallot, pulmonary atresia and other surgical procedures requiring reconstruction of the right ventricular outflow tract (RVOT).1–4 Even with the use… View more

Vascular Disease and Surgery

Intervention
Assessing the risk of Leaflet Motion Abnormality
Author(s): Luca Testa , Christopher M Cook Start date: Jan 16, 2018

Intervention
ACC 22: Findings from the CoreValve US Pivotal & SURTAVI Trials
Author(s): Michael J Reardon Added: 2 years ago
In this short interview, Dr Michael J Reardon (Houston Methodist DeBakey Heart and Vascular Center, US) shares the insights from the CoreValve US Pivotal & SURTAVI Trials presented at ACC.22 (NCT01586910). These trials investigated the five-year incidence, timing and predictors of haemodynamic valve deterioration of transcatheter (Medtronic CoreValve® System Transcatheter Aortic Valve… View more

Vascular Disease and Surgery

Intervention
Transseptal Mitral Valve Therapy
Author(s): Marvin H Eng , Dee Dee Wang Added: 3 years ago
Approximately 1.8% of the US population has mitral valve disease,1 and an estimated 106,000 surgeries per year are for the treatment of valvular heart disease.2 A total of 210,529 mitral surgeries were performed from 2000 to 2007, averaging approximately 30,000 mitral valve surgeries yearly in the US, accounting for both combined and isolated mitral procedures, with approximately 60% of surgeries… View more

Vascular Disease and Surgery

Intervention
SMART Trial
Author(s): Didier Tchétché Added: 1 week ago
Dr Didier Tchétché (Clinique Pasteur, Toulouse, FR) joins us to discuss findings from the SMART Trial.This prospective, multi-centre, randomised controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli and severe symptomatic aortic stenosis. At… View more

Intervention
Author(s): Grégory Ducrocq , Dominique Himbert , Eric Brochet , et al Added: 3 years ago
Aortic stenosis (AS) is currently the most frequent native valve disease in Europe and is most often seen in elderly patients with co-morbidities.1 Valve replacement is the definitive therapy for patients with severe AS who have symptoms or objective consequences such as left ventricular (LV) dysfunction.2,3 However, the risk of surgery may be higher in elderly patients with significant co… View more

Vascular Disease and Surgery

Intervention
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more

Vascular Disease and Surgery

Intervention